Podcast: Why Hyderabad's Biological E could be the dark horse in India's vaccine race
PodcastPodcast: Inside Forbes India
Märkige kuulatuks
Подпишитесь на уведомления о выходе новых выпусков подкаста
Forbes India's Manu Balachandran and Divya Shekhar take a jab at why this southern company, which may be a few laps behind the bigwigs in vaccine trials, could make up for lost time in its ability to scale. Will it play a big role in vaccinating India? Find out on this episode
Täpsemad andmed
- Vanusepiirang:
- 0+
- Lisatud LitResi:
- 16 märts 2024
- Kirjutamiskuupäev:
- 07 detsember 2020
- Kestus:
- 10 min. 58 s.
Raamat Forbes India "Podcast: Why Hyderabad's Biological E could be the dark horse in India's vaccine race" — ostke e-poest. Kirjutage kommentaare ja ülevaateid, hääletage oma lemmiku poolt.
Оставьте отзыв
Отзывы